BAL2420
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAL2420, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects [Phase 1]